Cargando…
Why do we need a new journal in autoimmunity?
A new online Journal of Autoimmune Diseases is created as an independent open access journal. In addition to the obvious advantages of the open access, the Journal will practice a double-blind reviewing of the manuscripts, which means that both the reviewers and the authors remain anonymous to each...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544945/ https://www.ncbi.nlm.nih.gov/pubmed/15679906 http://dx.doi.org/10.1186/1740-2557-1-1 |
_version_ | 1782122181051809792 |
---|---|
author | D'Cruz, David Ablamunits, Vitaly |
author_facet | D'Cruz, David Ablamunits, Vitaly |
author_sort | D'Cruz, David |
collection | PubMed |
description | A new online Journal of Autoimmune Diseases is created as an independent open access journal. In addition to the obvious advantages of the open access, the Journal will practice a double-blind reviewing of the manuscripts, which means that both the reviewers and the authors remain anonymous to each other. We believe that such a policy will reduce the influence of personal and other non-scientific factors on the reviewer's decision making. |
format | Text |
id | pubmed-544945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5449452005-01-26 Why do we need a new journal in autoimmunity? D'Cruz, David Ablamunits, Vitaly J Autoimmune Dis Editorial A new online Journal of Autoimmune Diseases is created as an independent open access journal. In addition to the obvious advantages of the open access, the Journal will practice a double-blind reviewing of the manuscripts, which means that both the reviewers and the authors remain anonymous to each other. We believe that such a policy will reduce the influence of personal and other non-scientific factors on the reviewer's decision making. BioMed Central 2004-10-13 /pmc/articles/PMC544945/ /pubmed/15679906 http://dx.doi.org/10.1186/1740-2557-1-1 Text en Copyright © 2004 D'Cruz and Ablamunits; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial D'Cruz, David Ablamunits, Vitaly Why do we need a new journal in autoimmunity? |
title | Why do we need a new journal in autoimmunity? |
title_full | Why do we need a new journal in autoimmunity? |
title_fullStr | Why do we need a new journal in autoimmunity? |
title_full_unstemmed | Why do we need a new journal in autoimmunity? |
title_short | Why do we need a new journal in autoimmunity? |
title_sort | why do we need a new journal in autoimmunity? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544945/ https://www.ncbi.nlm.nih.gov/pubmed/15679906 http://dx.doi.org/10.1186/1740-2557-1-1 |
work_keys_str_mv | AT dcruzdavid whydoweneedanewjournalinautoimmunity AT ablamunitsvitaly whydoweneedanewjournalinautoimmunity |